Philips has announced the global launch of Azurion, its next generation image-guided therapy platform that integrates advanced interventional tools into one clinician platform. Azurion is the next generation image-guided-therapy platform to enhance patient care and optimise lab productivity, a press release states.
Combining advancements in vascular surgery, interventional cardiology, oncology and neuroradiology, Azurion provides procedure cards that allow clinicians to pre-programme routine tasks and user preferences while state-of-the-art ergonomic design and an intuitive user interface lets clinicians swiftly and confidently perform a wide range of routine and complex procedures in the interventional lab.
Azurion is the result of a multi-year development program conducted in collaboration with leading clinicians in the field to acknowledge that with the rapid growth of image-guided therapy procedures, hospitals and health systems are increasingly faced with the need to control costs while improving their standards of care. Azurion has been designed to address these challenges and is equipped with new workflow options and performance dashboards, as well as an upcoming range of productivity improvement services.
Andy Rogers, head of Radiation Physics Nottingham University Hospitals NHS Trust comments: “We are proud to partner with Philips UKI and to be one of the first centres in the world to receive this new advanced concept in image-guided therapy. We have found the pairing of excellent image quality with low radiation dose a great advantage when undertaking complex and lengthy cardiac procedures, while Azurion’s ease of use has let us quickly train staff on the system and integrate it into the cardiac catch lab environment. We are very excited with the future possibilities of integrating more of our equipment into a single touch-screen user interface, which will drive improvements in lab efficiency and superior patient care.”
Having acquired Volcano Corporation in 2015, subsequently becoming a leader in advanced catheters for diagnosis and therapy, Philips is further expanding its market footprint in the image-guided therapy market with one of its largest global product launches in recent years.
The Azurion platform features over 1,000 new components, including an enhanced flat-panel detector and Philips’ newly developed ConnectOS operating system for the seamless integration of real-time information from all relevant technologies in the interventional lab. All of these components work together to deliver high image quality at ultra-low radiation exposure and real-time image processing on multiple work spots within the interventional lab. Parallel working enables the team of clinicians to complete different tasks simultaneously, saving valuable time without compromising quality of care.
“As a leader in image-guided therapy, we have been driving continuous innovation to address rising patient volumes and increased procedure complexity,” said Bert van Meurs, business leader Image Guided Therapy at Philips. “Hundreds of Philips developers, engineers and designers and dozens of our clinical partners across the world have collaborated to completely redesign the heart of our portfolio. With the launch of our new Azurion platform, which was designed to optimise system integration and lab performance, we can deliver new turnkey solutions that support our customers in maintaining high standards of quality and patient care at predictable costs.”